Ichor (NSDQ: ICHR) pre-announced some strong revenue numbers this morning, sending the stock up. Book the quick 43% gain in these calls, which expire mid-February. Read More
Archive
Filter
Bioverativ is jumping sharply while presenting at a JP Morgan conference in San Francisco. While no firm news is on the wire, there is obviously some good news swirling around the company. Book this quick 71% gain. Read More
Although we booked a fantastic 2-week gain in the Lam Research calls, Profit Catalyst Alert still owns options that should rise with bullish news in the semiconductor sector. We join hands with a bull on ANI Pharma and debate a bear on Celgene. Read More
Bullish spirits are alive and well in tech after turning sour just a few weeks ago. I still like the semiconductor equipment stocks but think a swift 43% gain is too good to pass up. Read More
Sell the January Steelcase calls. Unless the stock closes higher than $15 these calls will expire worthless. I do not foresee any news event that will move the stock much higher before expiration. Read More
2017 surpassed my expectations for the number of options and stock trades offered and the gains enjoyed. Look for a solid but rocky 2018 with sector rotation and little room in valuations for earnings misses. Read More
An incredibly busy two weeks for Profit Catalyst Alert. With six new bullish options trades recommended, which ones are still good buys? Celgene gets hit due to sloppy results in a new indication for its cancer drug and more. Read More
A recent Morgan Stanley downgrade crushed the semiconductor group. The call for lower pricing seems premature and offers investors a terrific buying opportunity. Buy calls on these equipment manufacturers who are less exposed to chip pricing swings. Read More